Here is BIGVU is one of the fastest-growing portfolio companies at www.intempo.ventures Do you want to Better promote your Business and to Write compelling scripts effortlessly with AI-powered assistance? Or Record your videos like a pro using our handy teleprompter feature? Or Edit your content seamlessly with automatic captions and user-friendly tools, or Share your creations across social media platforms without breaking a sweat? With BIGVU, anyone can quickly create professional videos with just their smartphone, without video editing skills. BIGVU is a TV studio in your pocket: teleprompter, automatic captions, branding with logo & motion titling, intros & outros. BigVu has a growing audience of more than 2.5 million users in over 70 countries. Producing high-quality videos took one hour and now takes minutes. Available on Android and IOS Now, you can also create your AI Talking Twin Avatar for Videos capable of speaking in 29 different languages. Say goodbye to the video creation hassle and hello to AI text-to-video. Scale your business, grow your content, and communicate effectively with your audience! You can join BigVu's next exciting webinar, where we'll show you how to Write, Record, and Edit Video Content Using Powerful AI: https://lnkd.in/d6Z8iju5 #VideoProduction #ContentCreation #AIinVideo #AIVideoTools #SmartEditing #TeleprompterTips #TeleprompterApp #OnCameraConfidence #SocialMediaTips #DigitalMarketing #ContentStrategy #VideoMarketing #TechForContentCreators #MarketingTips
Intempo Ventures
Investment Management
We look for early-stage hitech startups that will hit substantial markets on time
עלינו
Intempo Ventures is a Tel Aviv-based investment firm focused on partnering with visionary entrepreneurs in Israel and Barcelona (Spain ). We are seeking to join ambitious entrepreneurs who have the potential to become category leaders of the future. In particular, we look for early-stage Hitech companies that address substantial markets and offer simple solutions to their complex problems. Intempo Ventures targets Early-stage startups operating within sectors in which the project has a proven innovative edge. These include: FinTech (e-commerce payments), MedTech(Medical Devices) , BioTech(Sustainable proteins) and DeepTech(Photonics/Semiconductor). Our investment philosophy and brand are inspired by legendary investor Bill Gross, who famously said, "Timing is the single biggest reason startups succeed." This belief drives our strategic approach to identifying and nurturing startups with the right ideas at the right time. Our investment strategy targets pre-seed and seed-stage opportunities with a validated product-market fit, focusing on companies valued at $10 million or less. While we don’t typically serve as lead investors, we are unafraid to take the initiative and be the first to write a check into a promising business.
- אתר אינטרנט
-
http://www.intempo.ventures
קישור חיצוני עבור Intempo Ventures
- תעשייה
- Investment Management
- גודל החברה
- 2-10 עובדים
- משרדים ראשיים
- Tel Aviv
- סוג
- בבעלות פרטית
- הקמה
- 2021
- התמחויות
מיקומים
-
הראשי
Tel Aviv, IL
עובדים ב- Intempo Ventures
עדכונים
-
In collaboration with a team of distinguished researchers, Flying Spark, an innovative Thai-Israeli biotech company and part of the www.intempo.ventures portfolio, proudly introduces Bio.P7 oil—an advanced anti-aging ingredient set to revolutionize global skincare standards. Using cutting-edge biotech extraction methods at Flying Spark’s state-of-the-art facility in Thailand(https://flyingspark.com/), this breakthrough represents a significant leap in natural skincare, combining high efficacy with sustainability. Under CEO Eran Gronich´s lead the company is preparing itself to harvest the fruits of dedicated efforts in R&D and P&L. The anti-ageing cosmetics market is projected to grow at a compound annual growth rate (CAGR) of approximately 3.71% from 2024 to 2032. Flying Spark’s smart focus on this booming market positions it to capitalise on these emerging trends. Please see: https://lnkd.in/dyYKtBd4 Or read: https://lnkd.in/dXY4q8mK
-
Ark Surgical Ltd., a pioneering medical device company within the www.intempo.ventures portfolio, has secured $1.1 million to advance safer surgical solutions tailored specifically for Women's Health. Sealed between December 2023 and January 2024, this investment marks a pivotal milestone for Ark Surgical as it pursues its mission to improve women's healthcare with safer surgical interventions. The infusion of funds will predominantly fuel the company's strategic expansion efforts in the United States, particularly in promoting its FDA-cleared tissue containment system, the #LapBox. Entities in this funding round include Intempo Ventures, #NGT3, the Israel Innovation Authority (IIA), and the Israel Ministry of Economy and Industry. Additionally, Ark Surgical has garnered support from a distinguished U.S.-based medical device group comprising seasoned physicians and executives renowned for their extensive expertise in the healthcare landscape. #LapBox containment system directly addresses the FDA's imperative to mitigate the risk of undiagnosed cancer dissemination during tissue morcellation, all while enhancing patient outcomes by facilitating minimally invasive alternatives to conventional, higher-risk open surgeries. Learn more in Femtech Insider > https://lnkd.in/dtnpAA7E #womenshealth #gynecology #medtech #healthcareinvestment #medicaldevices
-
Intempo Ventures is thrilled to announce a groundbreaking development in the field of medical technology. Time is Brain, a pioneering startup under the umbrella of the www.intempo.ventures portfolio, has created #BraiN20®, a medical device specifically designed for the automated recording and analysis of neuronal electrical activity. Brain20® is a Stroke ECG. The device improves accuracy in patient selection for Endovascular Thrombectomy (EVT) treatment and enables real-time monitoring of cerebral viability during the EVT procedure. Brain20® also guides interventionists to enhance patient prognosis after treatment. We invite you to connect with Time is Brain at the Mobile World Congress in Barcelona. They will be at the 4YFN on the 26th and 27th in Hall 8.1 - Stand 8.1A40. Join them as they showcase the future of medical innovation and patient care. #stroke #neurology #medicaldevices #brainstroke #thrombectomy #endovascular
-
Dormotech Medical Ltd., the next generation of sleep tests, is since today an Intempo Ventures Digital Health portfolio company. Its DormoTech Vlab System will revolutionise home sleep testing, offering comprehensive polysomnograms (PSGs) characterised by high-quality sleep clinic data and unparalleled comfort in one's home. In our society, 40% of the population grapples with sleep disorders, negatively impacting both mental and physical well-being as well as longevity. Led by CEO Abed Nassir, a biomedical engineer with an MBA in finance and big data, DormoTech introduces a groundbreaking wearable home diagnostic device designed to combat these issues. The Vlab System stands out as a next-generation home sleep diagnostic device characterised by its personalisation, reusability, compact design, and user-friendly interface. Nightly, this cutting-edge medical device captures over 25 physiological data signals for each patient. DormoTech's Vlab System garnered Official FDA Clearance in October 2023, attesting to its adherence to rigorous regulatory standards. DormoTech is a MedTech incubator Galil Ofek Innovation member. This initiative is led by CEO Eyal Aviram, who guides Galil Ofek Innovation towards the forefront of medical technology advancements. #fda #healthinnovation #medicaldevices #sleepdisorders #sleepapnea #
-
Ark Surgical Ltd., part of the Intempo Ventures company portfolio, proudly announces a significant achievement. Stav Tori, CEO of Ark Surgical, shared today that the LapBox tissue containment system has received approval from the Medical Device Division of the Israeli Ministry of Health (AMAR) for marketing and sales in Israel. This accomplishment follows the FDA clearance obtained earlier this year. The LapBox manual morcellation system is a breakthrough for gynaecologists, providing them with a minimally invasive laparoscopic alternative to higher-risk open surgeries. Uniquely engineered to facilitate the safe and straightforward removal of tissue, the LapBox establishes a secure, enclosed environment, mitigating the risk of cancerous tissue dispersion during morcellation. Additionally, it enhances control and manoeuvrability, leading to improved outcomes for patients. With this approval, the LapBox is poised to revolutionise women's health care, offering a solution that prioritises safety and efficacy in minimally invasive procedures. For further insights into the LapBox solution, please visit >> https://lnkd.in/dWXB-wVc #medicaldevices #gynecology #womenhealth #cancerprevention